OPTIMA CAPITAL LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2070972 PORTLAND, OR

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$215,788

-$20,443 QoQ

Shares Held

1,708

+0.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#1,881

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

OPTIMA CAPITAL LLC holds $1,870,365 across 6 Drug Manufacturers - General names. GILD ranks #5 (11.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,666	$423,113
2	ABBV	AbbVie Inc.	1,645	$413,947
3	LLY	ELI LILLY & Co	286	$343,036
4	MRK	Merck & Co., Inc.	2,017	$259,184
5	GILD	Gilead Sciences, Inc. This page	1,708	$215,788
6	PFE	Pfizer Inc	8,941	$215,297

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$215,788	1,708	+0.8%	Shares	Defined	2026-07-24
2026-03-31	$236,231	1,695	+1.1%	Shares	Defined	2026-05-05
2025-12-31	$205,834	1,677	-12.5%	Shares	Defined	2026-01-23
2025-09-30	$212,676	1,916	+1.3%	Shares	Defined	2025-10-27
2025-06-30	$209,765	1,892	+1.0%	Shares	Sole	2025-07-15
2025-03-31	$209,981	1,874	—	Shares	Sole	2025-06-13
No filing history on record for this holder in this stock.